Recognising the need for the development of a cohort of appropriately qualified scientific, medical/dental and veterinary graduates, we are offering a research intensive, student-oriented MRes in Translational Medicine. The MRes in Translational Medicine provides high quality graduates with the research rigour, the innovation culture and the leadership skills to be at the forefront of this translational revolution and so develop a cohort of appropriately qualified scientific medical/dental and veterinary graduates.
Translational Medicine allows experimental findings in the research laboratory to be converted into real benefit for the health and well-being of the patient, through the development of new innovative diagnostic tools and therapeutic approaches.
The main objective of the MRes Programme in Translational Medicine is to provide high quality candidates with the research rigour, innovation culture and the leadership skills to be at the forefront of this translational revolution. Students will receive expert training in all aspects of translational medicine including how new experimental findings are translated into treatments for patients; the experimental steps in the process, the development of innovative solutions, management and leadership skills and an appreciation of marketing and financial aspects of translational medicine through interaction with business leaders and scientists from Biotech and Pharmacy
This research intensive programme incorporates a 38 week research project in an area selected by the student in consultation with the research project co-ordinator. student selected area.
QUB has an international reputation in translational medicine, achieved through the recognised metrics of high impact peer review publications, significant international research funding, the generation of exploitable novel intellectual property and the establishment of successful spin-out biotech companies. This ethos of innovation was recently recognised with the award of the Times Higher Education Entrepreneurial University of the Year.
This unique course offers students the chance to choose one of these three research streams with the indicated specialist modules:
Precision Cancer Medicine
This stream provides students with a unique opportunity to study cancer biology and perform innovative cancer research within the Centre for Cancer Research and Cell Biology (CCRCB). Prospective students are immersed in this precision medicine milieu from Day 1, providing for them the opportunity to understand the key principles in discovery cancer biology and how these research advances are translated for the benefit of cancer patients. The strong connectivity with both the biotech and biopharmaceutical sectors provides a stimulating translational environment, while also opening up potential doors for the student's future career.
This stream contains two complementary modules which significantly build on the foundation provided by undergraduate medicine or biomedical science to provide students with an advanced insight into current understanding of cardiovascular pathobiology and an appreciation of how this knowledge is being applied in the search for novel diagnostic, prognostic and therapeutic approaches for the clinical management of cardiovascular disease, which remains the leading cause of death worldwide. Students who select the Cardiovascular Medicine Stream will be taught and mentored within the Centre for Experimental Medicine which is a brand new, purpose-built institute (~7400m2) at the heart of the Health Sciences Campus. This building represents a significant investment (~£32m) by the University and boasts state-of-the-art research facilities which are supported by a world-leading research-intensive faculty, ensuring that all of our postgraduate students are exposed to a top quality training experience.
Inflammation, infection and Immunity
This stream exposes students to exciting concepts and their application in the field of infection biology, inflammatory processes and the role of immunity in health and disease. There will be detailed consideration of the role of the immune system in host defence and in disease. There is a strong emphasis is on current developments in this rapidly progressing field of translational medicine. Students learn how to manipulate the inflammatory/immune response and their interaction with microbes to identify, modify and prevent disease. Students will also be introduced to the concepts of clinical trials for new therapeutics, and the basic approach to designing a trial to test novel methods to diagnose/prevent or treat illness.
A minimum 2:1 honours degree (or equivalent) in a relevant biological subject is required. Evidence of equivalent professional qualifications (MBBS, BDS or BVSc) or relevant experience will be considered on an individual basis. Applicants may be required to undertake an interview.An IELTS score of 6.5 with not less than 6.0 in each of the four components: Elements of Listening, Reading, Speaking and Writing and achieved within the last 2 years or equivalent qualification.
18 July 2017
Recipient: Queen’s University Belfast
Insert previous message below for editing?
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need. Why not add a message here